Up to $7 million in research awards will accelerate the development of better, less-toxic children’s cancer treatments
Up to $7 million in research awards will accelerate the development of better, less-toxic children’s cancer treatmentsBethesda, Md. – October 5, 2018 - CureSearch for Children’s Cancer announced a request for applications (RFA) for high potential projects that address areas of unmet need in pediatric cancer, including high-risk, relapsed, or metastatic disease, adolescent and young adult patient populations, and/or the use of novel immunotherapy targets or modalities.
The awards will support revolutionary research and address all stages of the pediatric drug development pipeline, including:
· : Provides seed funding for bright researchers, early in their careers, pursuing exciting and novel research in pediatric oncology.
· : Funds scientific or technological innovation with the highest likelihood of identifying a breakthrough in childhood cancer treatments and becoming an impactful therapeutic option for children in the near term.
· Supports the advancement of clinical research to improve outcomes for pediatric cancer patients.
The application window opened Monday, October 5, 2018 via ProposalCENTRAL; award notifications will be released in March 2019. For more information about the CureSearch research award programs visit https://curesearch.org/
---About CureSearch for Children’s Cancer
CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md., works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch focuses on advancing the strongest research out of the laboratory and into clinical trials and marketplace, where better, less-toxic treatments can quickly help children.
Learn more about CureSearch by visiting our press room: https://curesearch.org/Press-
